From August 25 to 27, 2026, CPHI Korea 2026, one of Asia's most influential full-industry-chain events for pharmaceuticals and biopharmaceuticals, was grandly held at COEX Convention & Exhibition Center in Seoul. As a key player in the global pharmaceutical raw material sector, Topscience Biotech made a strong presence at Booth U19, showcasing its core products including Sodium Hyaluronate and PDRN, and engaging with industry peers from around the world.

During the event, Topscience Biotech's PDRN product stood out as the undisputed "star of the show," thanks to its exceptional quality and vast application potential. Numerous visitors stopped by the booth for in-depth discussions on PDRN's technical specifications, application scenarios, and collaboration opportunities. On-site feedback highlighted that the product's unique value in tissue repair and regeneration has earned widespread recognition from global brands, manufacturers, and R&D experts.

In addition to PDRN, our pharmaceutical-grade Sodium Hyaluronate also drew significant attention. Throughout the three-day exhibition, the atmosphere at the Topscience Biotech booth remained vibrant and engaging. As a key stop in the CPHI series, CPHI Korea brings together the world's premier pharmaceutical resources. Leveraging this international platform, Topscience Biotech not only demonstrated its technical strength in bioactive raw materials but also established meaningful connections with potential clients from South Korea, Asia, Europe, the Americas, and beyond—further expanding its global partnership network.

This participation marks not only a crucial step in Topscience Biotech's 2026 globalization strategy but also another milestone following a series of major industry events including in-cosmetics Korea and AMWC Korea. As CPHI Korea 2026 draws to a close, we look forward to exploring new possibilities for industry growth together with our global partners.